Clinical Trial Update: Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for DTT106 evaluating efficacy and safety in erectile dysfunction associated with benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Erectile Dysfunction

Drugs mentioned

• DTT106

Snippet

Sponsor: EMS | Conditions: Prostatic Hyperplasia, Benign, Erectile Dysfunction | Phase 3 | Status: NOT_YET_RECRUITING